VIEWS: 7 PAGES: 6 POSTED ON: 6/9/2012
ANEMIA IN PRIMARY CARE Jeanette M. Tetrault, M.D. Week 3 Learning Objectives: 1. Generate the relevant differential diagnoses for microcytic, normocytic, and macrocytic anemias 2. Evaluate a patient with microcytic anemia and know when further work-up is appropriate 3. Understand the work-up for B12 and folate deficiencies 4. Consider hemolytic anemia in the differential diagnosis of a patient with anemia CASE ONE: Ms. H. is a 28-year-old female with no past medical history who presents to your office to establish care. On review of systems, she admits to feeling “a little tired all the time” but attributes this to her life as a surgical resident. Her menstrual history is described as having regular periods, once monthly, for seven days at a time, with two to three days of “heavy” flow. Her physical exam is completely normal. Questions: 1. What test(s), if any, would you order? Formatted: Font: Bold, Not Italic Your major concern for a menstruating female who complains of mild fatigue is for anemia. More specifically, you should consider iron deficiency anemia. It would be reasonable to start with a CBC and specifically look at the MCV to look for a microcytic anemia. It would also be reasonable at this time to send a TSH and perform a depression screen, as these are other common treatable causes of non-specific fatigue. As the article points out, iron studies are often ambiguous and not often helpful. A ferritin level, however, may be helpful. CASE ONE CONTINUED: Ms. H. comes in for follow-up of her lab results two weeks later. You note that her hemoglobin is 11 mg/dL and her MCV is 76. 2. What should you do next? What if she said her periods lasted 5 days with normal flow? This patient is uncomplicated, and it would be reasonable, as she was found to have a microcytic anemia in the setting of heavy periods, to treat her empirically with iron supplements and re-check a CBC in four to six weeks to confirm a response. Additionally, she should be scheduled for a Pap smear and pelvic exam to rule out any pathology given her heavy bleeding. In the U.S., most iron deficiency results from blood loss. Gastrointestinal losses should be considered in all patients, and fecal occult blood screening should be performed if no other sources of blood loss can be identified. The optimal approach to menstruating women with iron deficiency anemia is unclear. All premenopausal women with positive fecal occult blood loss, anemia out of proportion to menstrual blood loss, abdominal symptoms, family history of GI malignancy, or age greater than 50 should undergo endoscopic evaluation.(Bini, 1998) Other causes of iron deficiency anemia include decreased iron absorption (i.e., celiac disease), intravascular hemolysis (which may be accompanied by hemoglobinuria or hemosideriuria), and gastric bypass surgery. One must also consider which iron formulation should be used. The most appropriate form of oral iron therapy is one containing iron salts such as ferrous fumerate, ferrous sulfate, or ferrous gluconate. The recommended daily dose is between 150-200mg of elemental iron daily. No evidence suggests that one preparation is more effective for the treatment of iron deficiency. Ferrous sulfate at 325 mg TID contains 195 mg of elemental iron. Absorption of iron is best when taken on an empty stomach. This regimen should increase hemoglobin 2 g/dL over the next three weeks. The most common complication of iron supplementation includes constipation, and patients should be counseled to increase water intake. Other side effects include nausea, epigastric tenderness, or vomiting. Other causes of microcytic anemia include anemia of chronic disease and thalassemia. Adults with previously undiagnosed thalassemia are most often heterozygous for alpha or beta thalassemia. Compared with iron deficiency anemia, the RBC count may be normal or increased, the MCV is usually markedly depressed (i.e., MCV <75fL), and the RDW is often normal (11.0-15%). Patients may have splenomegaly on examination. Peripheral smear shows abnormal RBC morphology, and a serum protein electrophoresis can be ordered for further evaluation of potential thalassemia trait. CASE TWO: Mr. A. is a 62-year-old black male with a history of diabetes and hypertension. At a recent visit to the ER for hyperglycemia, he had a CBC that showed a normal white count, a normal platelet count, hemoglobin of 11.0, MCV of 84, and RDW of 13% (normal range, 11.0-15%). His chemistry panel at that time showed a creatinine of 1.6, which you note is his baseline, but was otherwise normal. On review of systems, he denies fatigue, orthostasis, dizziness, melena, or hematochezia. Physical exam shows a blood pressure of 148/90, A-V nicking, and a soft systolic murmur. The rest of his exam is within normal limits. 3. What is the differential diagnosis for his anemia? First, African-American males have lower normal hemoglobin values than white males, by 1-2 g/dl, therefore, this may not be “anemic” for him. However, he has multiple possible risk factors for anemia: erythropoietin deficiency (from chronic kidney disease, as a result of longstanding diabetes and hypertension), and anemia of chronic disease (ACD) (secondary to diabetes). His anemia is normocytic; all of the above can present as such. Also in the differential for normocytic anemia are vitamin B12 or folate deficiency, hemolytic anemia, and primary bone marrow disorder. Often times, anemia may be multi-factorial. 4. What else would you do at this point? A repeat CBC with peripheral smear should be checked. Additionally, a ferritin level should be checked in this patient, to rule-out iron deficiency. A reticulocyte count may also be helpful—appropriately high with hemolysis and inappropriately low or normal in every other case. Suspicion for anemia of chronic kidney disease in this case is fairly high.(Weiss, 2005) Unless something further in his history suggested a greater possibility of hemolysis (e.g., jaundice, new onset pallor, splenomegaly, or gallstones) , it would be reasonable to defer the additional tests (including indirect bilirubin, LDH and haptoglobin) for now. CASE TWO CONTINUED: Mr. A. returns the next week to follow-up. His tests reveal an unchanged CBC, a ferritin of 120 and a reticulocyte count of 5%. He tells you at this visit that he forgot to mention that he had an earache the week prior to his ER visit and went to a walk in clinic and was given ampicillin. 5. How does this information change your differential diagnosis, if at all? Infection- or drug-related hemolysis becomes a possibility. Ampicillin can be a cause of hapten-associated, immune-mediated hemolytic anemia.(Dhaliwal, 2003) The history is consistent, there is nothing to support iron-deficiency, and the reticulocyte count is above normal. The indirect bilirubin, LDH, and haptoglobin should be sent. Drug-related hemolysis is typically autoimmune, so a Coombs test would also be reasonable. The first step in the treatment of drug-related hemolysis is to remove the offending agent and monitor the patient for ongoing hemolytic anemia. Exchange transfusion is reserved only for severe cases. CASE THREE: Mr. B. is an 18-year-old college student who came to see you for a school physical. His medical history is unremarkable. He takes no medications or herbal supplements, but occasionally takes a multivitamin. Social history is notable for occasional marijuana smoking and maintaining a vegan diet. Physical exam is normal. His lab values are notable for a hemoglobin of 10.5, hematocrit of 31.5, MCV of 107. 6. What is your differential diagnosis for this patient, and what tests would you send? He has a macrocytic anemia, which is commonly caused by nutritional deficiencies (vitamin B12, folate), drugs (alcohol, hydroxyurea, methotrexate, trimethoprim, zidovudine, and 5-FU), and primary bone marrow disorders. It would be important to take a good history from this patient regarding alcohol use. As a vegan, he is at high risk for vitamin B12 deficiency. A vitamin B12 level and folate level should be sent first. Serum folate is a reflection of short-term folate balance and, therefore, may have wide fluctuation over time. RBC folate may be a more adequate indicator of tissue folate stores since it reflects an average folate concentration over time. In this patient, very recent use of multivitamins could artificially normalize the serum folate level (e.g., he knew he was coming to the doctor so he restarted his multivitamin routine yesterday). It would also be reasonable to send a homocysteine level in addition to evaluate folate stores. Folate is required to convert homocysteine to methionine. If the homocysteine level is normal, then folate deficiency is not present. If it is elevated, folate may or may not be deficient, as other factors may interfere with this conversion or otherwise raise homocysteine levels. In certain instances (e.g., elderly patients, pregnancy, and in patients with low WBC counts) vitamin B12 may be spuriously low. If the B12 is low or borderline in patients with these characteristics, a more sensitive and highly specific test would be to check a methylmalonic acid (MMA) level. Vitamin B12 is a co-factor for the conversion of mehylmalonyl coenzyme A to succinyl coenzyme A. A normal MMA level makes the diagnosis of B12 deficiency extremely unlikely. CASE THREE CONTINUED: Mr. B’s labs results are remarkable for a vitamin B12 level of 170 (lower limit of normal is 180). The other studies sent are normal. 7. Are there any other tests that should be sent now? How should this patient be treated? Vitamin B12 deficiency occurs because of inadequate intake, malabsorption, or in the setting of pernicious anemia (autoantibodies to intrinsic factor blocking absorption). Antibodies to intrinsic factor should be sent now. The sensitivity of testing for antibodies to intrinsic factor ranges between 50 and 85%, with a specificity approaching 100%. Anti-parietal cell antibody testing has much less favorable operating characteristics with a sensitivity below 50%. If anti-intrinsic factor antibodies are present, the patient has pernicious anemia and will require vitamin B12 therapy. If negative, then he most likely has deficiency secondary to inadequate intake, as a vegan. Although the Schilling test has historical value, it is rarely used for the diagnosis of pernicious anemia. Pernicious anemia is generally treated with 1000 micrograms of vitamin B12 injected intramuscularly daily for one week followed by life-long monthly IM injections if the underlying disorder persists. There are no hypervitaminosis syndromes associated with vitamin B12 treatment, and the injections are inexpensive. Non-parenteral formulations are available and appear as effective as B12 injections, however, require greater patient compliance. High concentration oral B12 may be an option in some patients, and the dose ranges from 1-2 milligrams daily. The effectiveness of this treatment should be followed with measurement of vitamin B12 and MMA levels. Sublingual and intranasal preparations are also available but have variable levels of absorption. This chapter was adapted from prior chapter written by Dr. Meeta Prasad, M.D. in 2005, Fifth Edition, Yale Office-based Medicine Curriculum. Primary Reference: 1. Tefferi, A. Anemia in adults: A contemporary approach to diagnosis. Mayo Clinic Proceedings. 2003; 78: 1274-1280. http://search.ebscohost.com/login.aspx?direct=true&db=aph&AN=10943682&site=ehost-live Additional References: 2. Weiss, G. et al. Anemia of chronic disease. New England Journal of Medicine. 2005; 352: 1011-1023. 3. Dhaliwal, G. et al. Hemolytic anemia. American Family Physician. 2003; 69 (11): 2599-2606. 4. Bini, EJ, Micale, PL, Weinshel, EH. Evaluation of the gastrointestinal tract in premenopausal women with iron deficiency anemia. Am J Med 1998; 105:281-6. Jeanette Tetrault completed both residency and chief residency with the Yale Primary Care Internal Medicine Residency program. She subsequently completed a clinical epidemiology fellowship in the Ambulatory Care Fellowship at the West Haven VA hospital. She is currently an instructor of medicine in the Department of General Internal Medicine at Yale University School of Medicine. Her clinical and research interests include HIV, Hepatitis C, and substance use disorders.
"ANEMIA ANEMIA IN PRIMARY CARE"